A federal judge in New Jersey tossed lawsuits from Johnson & Johnson and Bristol Myers Squibb questioning the constitutionality of the federal government requiring drugmakers to negotiate with ...

A federal judge in New Jersey on Monday rejected Johnson & Johnson's and Bristol Myers Squibb's legal challenges to the Biden administration's Medicare drug-price negotiations, ruling that the program ...

Johnson & Johnson (NYSE:JNJ) and Bristol Myers Squibb (NYSE:BMY) have become the latest industry participants to lose legal challenges against the Medicare drug price negotiation program, a major ...

Johnson & Johnson will become the first drug maker to begin showing the list price of its prescription drugs in television ads; in a 5-4 decision, the Supreme Court blocked a Louisiana law that ...

The Biden Administration this morning revealed the first 10 drugs for which Medicare will negotiate prices (which will go into effect in 2026) under the Inflation Reduction Act (IRA). "Despite Big ...